Healthcare Forum - 170419

The PMI Atlanta Healthcare Forum has 9 planned sessions throughout 2017. Proposed topics include IT & IT PMO in Healthcare, Healthcare SME/Domain Forums such as Clinical, Laboratory, Research, Tomorrow's Healthcare & Government practices/law, Thought Leadership in Healthcare, and Innovation in Healthcare Technology.

Keynote Presentation:  "How a Combination of Treatments and Vaccines Is Creating a Paradigm Shift in Combating Infectious Diseases" presented by Darnisha Grant Harrison, BS, President and CEO, Ennaid Therapeutics

 

Light refreshments and beverages will be provided.

Earn one PDU for attending this event.

When
Wednesday, April 19, 2017
6:00 PM - 8:00 PM

Where
Philips Healthcare
13560 Morris Road
PHA University Room
Alpharetta, Georgia 30004
770-510-1444

Fees
PMI Atlanta Member: $12.00, Early Bird Rate $10.00 through April 12th
Non-Member: $15.00, Early Bird Rate $13.00 through April 12th

Please note: Effective May 2016, Forums will no longer accept cash registrations at the door.  Please register in advance or via credit card at the door.

---

Presentation Details:

In the history of vaccines only one virus has been eradicated; can you guess which disease that is?

Viruses are invisible threats. The nine deadliest are, Small pox, influenza, HIV, retroviruses, measles, yellow fever, dengue, Lassa virus and Ebola. Many others are very harmful including, Zika virus, bubonic plague, H1N1, SARS, and chikungunya, often posing an economic burden greater than $39 billion globally.

We will discuss the paradigm shifts in global health that will truly combat and cure some of the afore-mentioned viruses, thus ending the Science of these Epidemics.

Talent Triangle Category: Leadership

Darnisha Harrison is the President & CEO of Ennaid Therapeutics. As the company’s Head, she is responsible for guiding the company toward its intention of being first-to-market with the world’s first therapeutic cure for two of the most notorious mosquito-borne diseases in the world, Zika virus and dengue virus.

Once a Microbiologist and Chemist, Darnisha is now a nationally recognized pharmaceutical entrepreneur by Newsweek Magazine and has greater than twenty-three years’ experience in the Life Sciences.

Prior to founding Ennaid Therapeutics, she spent three years as a scientist, most notably at Amgen and the University of Georgia, and fifteen years in Business Development/Licensing as a Director in various companies within the pharmaceutical industry. 

She is an accomplished negotiator and deal-maker in identifying, negotiating and closing drug development deals and strategic collaborations. Darnisha is accomplished in technology acquisition and licensing, strategic business development, business planning and brisk, successful execution of such plans. 

A member of the American Association for the Advancement of Science, the New York Academy of Sciences, The World Chamber of Commerce and Women In BIO; Darnisha received a B.S. in Microbiology and Minor in Chemistry from LSU.

Meeting content, presenter, and location are subject to change. Refunds will not be made for changes in meeting content, presenters, or locations. 

Logging PDUs:

PDUs can be claimed here.

For detailed instructions, please visit the CCRS User Guide.